ClinicalTrials.gg
RecruitingNCT03409133Updated Mar 6, 2026

Feasibility of Neural Feedback for Lower Limb Amputees

An interventional study of Stimulating nerve electrodes and intramuscular recording electrodes in Amputation, sponsored by Louis Stokes VA Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-06.

Sponsored by Louis Stokes VA Medical Center · Not applicable, Interventional, and Device feasibility

From the registry’s dates

  • Registered 2 years 1 month after the study started (first participant enrolled Nov 2015, registered Dec 2017).
  • Started Nov 2015; still recruiting 11 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the effectiveness of providing sensation of the missing limb to individuals with lower limb loss, including above and below knee amputees. The approach involves delivering small electrical currents directly to remaining nerves via implanted stimulating electrodes. These small electrical currents cause the nerves to generate signals that are then transferred to your brain similar to how information about the foot and lower limb used to be transferred to your brain prior to the amputation.

Individuals also have the option to have recording electrodes implanted within muscles of the lower limb(s) in an attempt to develop a motor controller that would enable the user to have intuitive control of a robotic prosthetic leg.

Read the detailed description

Electrodes are surgically implanted on one to four nerves of the residual limb. An external wearable device controls the delivery of electrical pulses to the implanted system. The participant will be asked to verbally describe the perceived sensations and highlight their locations on a drawing of a foot presented to them on an electronic screen. An instrumented prosthesis will be developed such that perceived sensations would correspond to prosthesis interactions with the floor. This instrumented prosthesis, also known as a sensory neuroprosthesis, will be worn while the participant is engaging in various functional tasks, such as standing, walking, or climbing stairs, or with visual or mental distractions.

Intramuscular recording electrodes can be implanted in the lower limb(s) and/or hip muscles in order to obtain electromyography (EMG) signals. The EMG recordings from the residual muscles will be used to develop an algorithm which can operate an advanced robotic prosthesis in which the movement of the joint(s) could be controlled.

02

Conditions studied

  • Amputation

Browse trials for

Keywords

  • prosthesis user
  • phantom sensation
  • sensory feedback
  • prosthesis
  • amputee
  • amputation
  • limb loss
  • robotic prosthesis
  • neuroprosthesis
  • sensory restoration
  • robotic
  • electromyography
  • EMG
  • sensation
  • myoelectric
03

In context

Phantom Limb

163 studies on the registry are indexed under Phantom Limb; 35 are open to participants now.

This study's planned enrollment of 15 is below the median of 30 across 125 interventional studies indexed under Phantom Limb.

Browse Phantom Limb studies →

Lead sponsor

Louis Stokes VA Medical Center is the lead sponsor of 15 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults age 18 or greater
  • Chronic, medically stable ( > 3 months) trans-tibial or trans-femoral amputation at the time of implant surgery.
  • Potential user of trans-tibial or trans-femoral prostheses for standing or walking
  • Viable target nerves in the lower extremity as determined by standard-of-care clinical tests of nerve conduction, response to stimulation, sensory evoked potentials and the like
  • Good skin integrity and personal hygiene
  • Absence of deficiencies, seizure disorders or cardiac abnormalities contraindicating stimulation
  • Sufficient social support and personal ability to tolerate study procedures and comply with follow-up schedule

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled diabetes to a degree that would preclude surgery
  • Significant vascular disease
  • Chronic skin ulcerations
  • Significant history of poor wound healing
  • Significant history of uncontrolled infections
  • Active infection
  • Significant pain in the residual or phantom limb
  • Pregnancy
  • Inability to speak English
  • Expectation that MRI will be required at any point for the duration of study or while percutaneous leads are in place
  • Severe neurological conditions that significantly impair balance or mobility to an extent that independent ambulation is impossible without assistance ( as determined by a healthcare provider)
  • Appropriate body habitus (height and weight within acceptable limits as determined by study physician)
  • Poor surgical candidate
  • Psychiatric or cognitive conditions that could affect cooperation or understanding of instructions and willingness to undergo psychological evaluation, if recommended by study surgeons or investigators.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Stimulating nerve electrodes & intramuscular recording electrodes

    Fifteen subjects with lower limb amputation will have multi-contact stimulating nerve cuff electrodes implanted around the nerves in their residual limb. These electrodes will be connected to temporary percutaneous leads. During experimental testing, a small amount of electrical current will be delivered to the nerves through multi-contact nerve cuff electrodes. Participants also have the option to have recording electrodes implanted within muscles in their lower limb(s). These muscles are associated with prosthetic movement, and recordings from these muscles will be used to develop a controller for a robotic myoelectric prosthesis.

    Device: Stimulating nerve electrodes and intramuscular recording electrodes

Interventions

  • DeviceStimulating nerve electrodes and intramuscular recording electrodes

    See Arm Description

06

What researchers measure

Primary outcomes

  1. Stimulation Thresholds

    Quantify the minimum stimulation required to evoke electrically induced sensations on the phantom limb.

    Time frame: 9 months post implant

  2. Functional Gait Assessment (FGA)

    The Functional Gait Assessment is a 10 task test that measures postural stability. Each task is scored from 0 -3 with 0 indicating severe impairment in the task and 3 indicating normal ambulation. The scores are combined to give a total score. The maximum score is 30. A higher score indicates a better outcome.

    Time frame: 1 year post implant

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Sheehan A, Siu R, Schmitt M, Vala J, Wright J, Kim D, Li S, Graczyk E, Triolo RJ, Charkhkar H. Impact of Long-Term Home and Community Use of a Lower Limb Sensory Neuroprosthesis. Res Sq [Preprint]. 2025 Sep 19:rs.3.rs-7412528. doi: 10.21203/rs.3.rs-7412528/v1. PubMed 41001531 ↗

Individual participant data

Plan to share: Yes — Data obtained through this study may be provided to qualified researchers with academic interest in neuroprostheses and amputee research. The shared data will be coded, with no PHI included. Approval of the request by local IRB and review of the PI(s) are prerequisites to the sharing of data with the requesting party.

Supporting information: Statistical analysis plan, Analytic code

Time frame: Upon request, IPD sharing will begin 6 months after publication and will be available for up to 1 year. Extensions will be considered on a case-by-case basis.

Access criteria: Access to IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of the request. Based on the extent of the request, written approvals from local IRB and execution of a Data Sharing Agreement (DSA) might be prerequisite. For more information or to submit a request, please contact Aarika.Sheehan@va.gov.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03409133
Lead sponsor
Louis Stokes VA Medical Center
Collaborators
Case Western Reserve University, United States Department of Defense
Responsible party
Ronald Triolo (Senior Research Career Scientist, US Department of Veterans Affairs,, Louis Stokes VA Medical Center) — Principal investigator
First posted
Jan 24, 2018
Start date
Nov 5, 2015
Primary completion
Sep 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Mar 6, 2026

Study contacts

Aarika Sheehan, PT, DPT
Contact
Aarika.Sheehan@va.gov
216-791-3800 ext. 65832
jessica jarvela, MS
Contact
jessica.jarvela@va.gov
216-769-0531
Ronald Triolo, PhD
principal investigator · Louis Stokes VA Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion